Evidence map›Paper›PMID 36405716›Full record

ArticleFrontiers in immunology2022

Identification of diagnostic genes for both Alzheimer's disease and Metabolic syndrome by the machine learning algorithm.

Jinwei Li, Yang Zhang, Tanli Lu, Rui Liang, Zhikang Wu, Meimei Liu, Linyao Qin, Hongmou Chen, Xianlei Yan, Shan Deng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Metabolic Syndrome and Dementia Risk in Older Adults: A Narrative Review.The Kaohsiung journal of medical sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. HucMSCs-Derived Extracellular Vesicles Deliver RPS27A Protein to Manipulate the MDM2-P53 Axis and Ameliorate Neurological Dysfunction in Parkinson's Disease.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Jinwei LiDepartment of Neurosurgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Yang ZhangGeneral Surgery, The First Affiliated Hospital of Dali University, Dali, China.
Tanli LuDepartment of Neurology, The Tenth Affiliated Hospital of Guangxi Medical University, Qinzhou, China.
Rui LiangCollege of Bioengineering, Chongqing University, Chongqing, China.
Zhikang WuDepartment of Neurosurgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Meimei LiuDepartment of Neurosurgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Linyao QinDepartment of Neurosurgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Hongmou ChenDepartment of Neurosurgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Xianlei YanDepartment of Neurosurgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Shan DengDepartment of Neurology, The Fourth Affliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China.
Jiemin ZhengDepartment of Neurosurgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Quan LiuDepartment of Neurosurgery, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Fourth Affiliated Hospital of Guangxi Medical University · CNChongqing University · CNDali University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Alzheimer's disease is the most common neurodegenerative disease worldwide. Metabolic syndrome is the most common metabolic and endocrine disease in the elderly. Some studies have suggested a possible association between MetS and AD, but few studied genes that have a co-diagnostic role in both diseases. Methods: The microarray data of AD (GSE63060 and GSE63061 were merged after the batch effect was removed) and MetS (GSE98895) in the GEO database were downloaded. The WGCNA was used to identify the co-expression modules related to AD and MetS. RF and LASSO were used to identify the candidate genes. Machine learning XGBoost improves the diagnostic effect of hub gene in AD and MetS. The CIBERSORT algorithm was performed to assess immune cell infiltration MetS and AD samples and to investigate the relationship between biomarkers and infiltrating immune cells. The peripheral blood mononuclear cells (PBMCs) single-cell RNA (scRNA) sequencing data from patients with AD and normal individuals were visualized with the Seurat standard flow dimension reduction clustering the metabolic pathway activity changes each cell with ssGSEA. Results: The brown module was identified as the significant module with AD and MetS. GO analysis of shared genes showed that intracellular transport and establishment of localization in cell and organelle organization were enriched in the pathophysiology of AD and MetS. By using RF and Lasso learning methods, we finally obtained eight diagnostic genes, namely Conclusion: We identified genes with common diagnostic effects on both MetS and AD, and found genes involved in multiple metabolic pathways associated with various immune cells.

Indexed as

Alzheimer DiseaseMetabolic SyndromeNeurodegenerative DiseasesAgedAlgorithmsBiomarkersHumansLeukocytes, MononuclearMachine LearningsnRNP Core ProteinsBiomarkerssnRNP Core ProteinsSNRPG protein, humanAlzheimer’s diseaseimmune infiltrationmachine learning algorithmmetabolic syndromesingle cell sequencingXGBost

Identifiers

PMID36405716
PMCPMC9667080
OpenAlexW4308128920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.